B

BiohacksAI

Evidence-Based Biohacking

Patent Pending
BiohacksAI/Mechanism Hypothesis/Butylscopolammonium Bromide Antimuscarinic quaternary ammonium derivative of scopolamine used to treat cramps in gastrointestinal, urinary, uterine, and biliary tracts, and to facilitate radiologic visualization of

Butylscopolammonium Bromide Antimuscarinic quaternary ammonium derivative of scopolamine used to treat cramps in gastrointestinal, urinary, uterine, and biliary tracts, and to facilitate radiologic visualization of — Mechanism Gap Analysis

HYPOTHESIS_ENGINE_v1.0 · Corpus v20260227-01 · Deterministic graph-traversal

Known Targets

CYP2D6CHRM1CHRM5CHRM4ANO1

5 known targets mapped from PubChem bioassay data

Pathway Context

Uncovered Pathway Targets

166 total
ADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2+156 more…

Genes present in the top pathway union that Butylscopolammonium Bromide Antimuscarinic quaternary ammonium derivative of scopolamine used to treat cramps in gastrointestinal, urinary, uterine, and biliary tracts, and to facilitate radiologic visualization of does not directly modulate.

Top Stack Candidates

Aripiprazole

#1 gap-filler · 33 targets covered · evidence score 52.0

score 6,921.872
ADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1AVPR1A+21
Astemizole Antihistamine drug now withdrawn from

#2 gap-filler · 30 targets covered · evidence score 48.7

score 6,274.735
ADRA1AADRA2AADRA2CADRB2APLNRAVPR1ACHRM2CHRM3DRD1DRD2DRD3DRD4+18

668 more candidates · full stack optimisation locked

Enter your API token to unlock the complete analysis.

BiohacksAI maps biological mechanisms. It does not recommend compounds. Results generated by HYPOTHESIS_ENGINE_v1.0.